InvestorsHub Logo
Followers 2
Posts 265
Boards Moderated 0
Alias Born 06/27/2016

Re: McMagyar post# 70276

Wednesday, 07/27/2016 10:46:01 AM

Wednesday, July 27, 2016 10:46:01 AM

Post# of 463770
Is there some FDA requirement that when you do a pivotal for a new AD drug that most of the trial must combo the drug with current SOC? AF indicated they do this because "that's how doctors treat patients" but if the FDA approves a new drug that is clearly better than SOC WITHOUT using SOC then why would docs not simply prescribe the new drug alone?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News